Viewing Study NCT05154851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-05-21 @ 10:54 AM
Study NCT ID: NCT05154851
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-09-29
First Post: 2021-12-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.
Sponsor: Hope Biosciences Research Foundation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congenital Muscular Dystrophy Due to Lamin A/C Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CMD View
None Muscular Dystrophy View
None Congenital View
None Stem cells View
None L-CMD View